A peptide Certificate of Analysis (COA) is one of the most useful documents a laboratory can request, and one of the most frequently misread. It is a compact analytical summary that tells a researcher what is actually in a vial — the peptide's identity, its measured purity, and the lab conditions under which those results were obtained. Yet across the research-materials landscape, COAs vary wildly in format, rigour and honesty. This article explains how to read a peptide COA properly, what an HPLC purity value really means, how mass spectrometry complements chromatography, and what a well-documented batch should look like.
What a peptide Certificate of Analysis (COA) is
A peptide COA is a batch-specific analytical report. It is issued by a laboratory that has physically tested a sample from a defined production lot and recorded quantitative measurements against reference standards. A COA should tell you, at minimum:
- The peptide's identity — its name, sequence, molecular weight and, where relevant, its calculated versus observed mass.
- The batch or lot number it was drawn from.
- The analytical methods used, along with the instrument, column, mobile phase and detection wavelength where applicable.
- The numerical results produced by those methods, expressed with the appropriate precision.
- The date of testing and the signature or authorisation of the analyst or laboratory.
The COA is not the same thing as a specification sheet, a product label, or a marketing claim. A specification sheet describes the target purity of a product line in general. A COA describes what a specific batch actually measured on a specific day, using a specific method. It is the difference between "this is what we aim for" and "this is what we found."
Why batch-specific COAs matter
Peptide synthesis is a chemistry-intensive process. Even within a single supplier's product range, purity can vary from batch to batch depending on solid-phase synthesis efficiency, side-chain protection strategy, cleavage conditions, purification yield and lyophilisation quality. A COA that is generic — one that could apply to any batch — provides no reassurance about the vial in front of you.
A batch-specific COA answers a simple question: for this particular lot of material, what did an analyst measure? It ties analytical results directly to a production run, so if a research group observes anomalous behaviour in an assay, they can trace back to the exact batch analysed and, where necessary, request re-analysis. For an extended discussion see why batch-specific peptide COAs matter.
How HPLC is used to assess peptide purity
High-Performance Liquid Chromatography (HPLC) is the workhorse technique for peptide purity assessment. In simple terms, it separates the components of a dissolved sample by pushing them through a chromatography column under high pressure and detecting each component as it emerges. For a deeper explanation, see the HPLC peptide testing guide.
For peptides, a typical purity assay uses reversed-phase HPLC (RP-HPLC) with a C18 column, an acidic aqueous mobile phase gradient (often water/acetonitrile with trifluoroacetic acid or formic acid), and ultraviolet detection at 214 nm — the wavelength at which the peptide backbone's amide bond absorbs strongly. As the sample flows through the column, different molecules travel at different speeds depending on their hydrophobicity, resulting in separate peaks on the resulting chromatogram. The main peak — corresponding to the target peptide — is compared against any smaller peaks representing impurities, incomplete sequences, oxidation products or by-products of synthesis.
How to interpret an HPLC purity percentage
An HPLC purity result is usually expressed as a percentage, and it is calculated as the area of the main peak divided by the total area of all peaks on the chromatogram. A result of "99.5% purity by HPLC" therefore means that 99.5% of the total UV-absorbing signal at the detection wavelength came from the main peak. Two subtleties matter here:
- The percentage is a measure of relative peak area, not absolute concentration. It tells you what fraction of the detected material is your target — not how much of your target is in the vial.
- The result is only as reliable as the method. A short run with poor gradient resolution may fail to separate closely related impurities from the main peak, artificially inflating the purity value.
A well-written COA will state the column used, the flow rate, the gradient profile, the detection wavelength and the run time. Without those details, a purity number is difficult to evaluate. For a longer treatment see what does 99% peptide purity actually mean?
What mass spectrometry tells researchers
Where HPLC answers "how pure is this sample?" mass spectrometry (MS) answers a different question: "what is this sample?" A mass spectrometer ionises molecules and measures their mass-to-charge ratio (m/z), producing a spectrum whose peaks correspond to the exact molecular mass of the analytes present. For peptides, MS is used to confirm identity — the observed mass of the main peak is compared against the theoretical mass calculated from the peptide's amino-acid sequence. A match within a few tenths of a Dalton confirms that the sequence assembled during synthesis matches the intended target. Full detail in LC-MS peptide testing explained.
Common MS techniques for peptides include ESI-MS (electrospray ionisation) — soft ionisation, well suited to peptides in aqueous or organic solution — and MALDI-TOF (matrix-assisted laser desorption/ionisation, time-of-flight), useful for larger peptides and for rapid screening. Where high-resolution MS is used, small mass shifts can reveal specific modifications such as oxidation, deamidation or truncation — all common side-products of peptide synthesis.
Why HPLC and mass spectrometry complement each other
HPLC and MS answer different questions, and used together they give a much more complete picture than either alone. HPLC tells you how much of your sample is the main species (relative purity). MS tells you what that main species actually is (identity confirmation). A high HPLC purity value alone does not guarantee that the peptide is the correct one. A sample could be 99% "pure" — meaning 99% one substance — but that substance could be a truncated sequence, an oxidised variant, or an entirely different peptide. Only mass spectrometry can rule this out. A rigorous peptide COA typically includes both: an HPLC chromatogram with a purity percentage, and an MS spectrum with observed and theoretical mass values.
What a "99% purity" claim actually means
"99% pure" is a phrase used loosely across the peptide market. In its strictest analytical sense, it should mean: when analysed by a specified HPLC method at a specified wavelength, the main peak accounts for 99% or more of the total integrated peak area. That is a useful statement. It is also a bounded one. It does not mean 99% of the vial's contents by mass are the peptide (moisture, counter-ions from trifluoroacetate salts, and other non-UV-absorbing components are not captured by UV detection at 214 nm), nor that the peptide is free of every possible related impurity — only those that absorb at the detection wavelength and elute within the run window. Reading a COA well means reading the fine print.
Why batch/lot numbers and traceability are important
A batch or lot number is the primary key that links a physical vial to its analytical documentation. On a well-documented product, that number appears on the vial label, on the outer packaging, and on the COA itself, matching the vial exactly. When those three references agree, the traceability chain is intact. When they don't — or when a supplier can only produce a generic COA that isn't tied to a specific lot — the research group has no way to verify that the analytical results being cited actually describe the material in hand. For a practical walkthrough see how to verify a peptide Certificate of Analysis.
Third-party testing versus supplier-provided documentation
A COA is either supplier-provided (results produced by the same organisation that manufactures or resells the peptide) or third-party (results produced by an independent laboratory with no commercial interest in the outcome). Both can be legitimate. In-house testing at reputable manufacturers is often the fastest way to release well-characterised material. However, third-party testing removes an obvious conflict of interest. A well-run supplier is transparent about which is which. Where a third-party laboratory is used, the COA will name the laboratory, list its accreditation status where relevant, and typically bear the laboratory's own letterhead or report reference. Peptovia Research works with independent analytical laboratories for batch verification — see our Certificate of Analysis page for current examples.
Common COA red flags researchers should look for
Not every COA is useful, and some are actively misleading. Common warning signs include: no batch or lot number; a purity percentage without method details; no chromatogram or mass spectrum image; a single COA presented as evidence for multiple different batches; suspiciously identical purity figures across every product; reports dated months or years before the batch was manufactured; no analyst signature, laboratory name or issuing address; and reference to human dosing, clinical outcomes or therapeutic claims. None of these on its own is proof of a problem, but each is a reason to ask for further information.
What a COA can and cannot demonstrate
A COA is a chemistry document. It describes what an analytical laboratory measured, using specified methods, on a specified date, from a specified batch. It can support statements about identity, purity, and physical characteristics of research material. It cannot, by itself, demonstrate biological activity in any assay (that requires functional testing), safety for any type of use (a COA is not a toxicology report or a clinical dossier), or suitability for a specific application (that determination rests with the research group).
Peptovia Research's approach to analytical transparency
At Peptovia Research, our position on analytical documentation is that it should be visible, batch-specific, and produced by an independent laboratory wherever possible. Recent third-party certificates are available on our Certificate of Analysis page. Researchers who require the COA for a specific batch received are welcome to request it via our contact form — quoting the batch code from the vial label.
Conclusion
A peptide Certificate of Analysis is a compact but powerful document. Read carefully, it tells a researcher what the material actually is, how pure it was measured to be, how those measurements were made, and how confident to be in them. Read carelessly — or accepted without scrutiny — it can create false confidence in material of unknown quality. The best defence against unreliable documentation is a habit of asking the same questions every time: Which batch? Which methods? Which laboratory? Which date?
Research Use Only — All information in this article is provided for research and educational purposes. Peptovia Research products are intended strictly for in-vitro laboratory research and are not for human or veterinary use.